Anne Andersson

Kontakt

090-785 78 87

Verksam som

Läkare vid Institutionen för diagnostik och intervention Enhet: Onkologi

27C, Målpunkt QC31, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE

BMJ Open, BMJ Publishing Group Ltd 2025, Vol. 15, (8)

Matikas, Alexios; Naume, Bjørn; Wildiers, Hans; et al.

Adherence to adjuvant endocrine therapy after breast cancer in Sweden - a nationwide cohort study in 1-, 3- and 5-year survivors with a focus on regional differences

Acta Oncologica, Uppsala: MJS Publishing, Medical Journals Sweden AB 2024, Vol. 63 : 901-908

De Jong, Anna; Von Wachenfeldt, Anna; Nyström, Lennarth; et al.

Age-specific differences in tumour characteristics between screen-detected and non-screen-detected breast cancers in women aged 40–74 at diagnosis in Sweden from 2008 to 2017

Journal of Medical Screening, Sage Publications 2024, Vol. 31, (4) : 248-257

Jonsson, Håkan; Andersson, Anne; Mao, Zheng; et al.

Age-specific differences in breast cancer treatment between screen-detected and non-screen-detected breast cancers in women aged 40-74 years at diagnosis in Sweden 2008-2017

Acta Oncologica, Medical Journals Sweden 2024, Vol. 63 : 552-556

Jonsson, Håkan; Andersson, Anne; Mao, Zheng; et al.

Tailored dose-dense versus standard adjuvant chemotherapy for high-risk early breast cancer: end-of-study results of the randomized PANTHER trial

Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO) 2024, Vol. 42, (26) : 3077-3082

Matikas, Alexios; Möbus, Volker; Greil, Richard; et al.

The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the swedish phase ii randomized predix HER2 trial

Breast Cancer Research and Treatment, Springer 2024, Vol. 204, (2) : 299-308

Zhu, Yajing; Zerdes, Ioannis; Matikas, Alexios; et al.

Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study

Free Radical Biology & Medicine, Elsevier 2023, Vol. 209 : 381-393

Hughes, David J.; Schomburg, Lutz; Jenab, Mazda; et al.

Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk

Breast Cancer Research and Treatment, Springer Nature 2023, Vol. 198, (2) : 361-368

Sund, Maria; Garmo, Hans; Andersson, Anne; et al.

Receptor conversion and survival in breast cancer liver metastases

Breast Cancer Research, BioMed Central (BMC) 2023, Vol. 25, (1)

Sundén, Marcus; Norgren, Sofia; Lundqvist, Robert; et al.

High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma: is there a need for intervention in long-term survivors?

Upsala Journal of Medical Sciences, Upsala Medical Society 2021, Vol. 126

Andersson, Anne; Enblad, Gunilla; Erlanson, Martin; et al.

Neoadjuvant trastuzumab, pertuzumab, and docetaxel vs trastuzumab emtansine in patients with ERBB2-positive breast cancer

JAMA Oncology, American Medical Association (AMA) 2021, Vol. 7, (9) : 1360-1367

Hatschek, Thomas; Foukakis, Theodoros; Bjöhle, Judith; et al.

Surgical treatment of breast cancer liver metastases: A nationwide registry-based case control study

European Journal of Surgical Oncology, Elsevier 2020, Vol. 46, (6) : 1006-1012

Sundén, Marcus; Hermansson, Cecilia; Taflin, Helena; et al.

Adherence to adjuvant endocrine therapy after breast cancer in Sweden 2008-2010: a nationwide survey

American Society of Clinical Oncology 2019

Andersson, Anne; von Wachenfeldt Väppling, Anna; de Jong, Anna; et al.

Docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer: results from the Swedish PREDIX HER2 trial identifying a new potential de-escalation standard?

Journal of Clinical Oncology, American Society of Clinical Oncology 2019, Vol. 37, (15) : 501-501

Bergh, Jonas C. S.; Andersson, Anne; Bjohle, Judith; et al.

Journal of Clinical Oncology, American Society of Clinical Oncology 2019, Vol. 37, (15) : 583-583

Brandberg, Yvonne; Andersson, Anne; Bjohle, Judith; et al.

Biverkningar vid antihormonell behandling påverkar följsamhet: Viktigt vara medveten om problemen för att motivera patienter att fullfölja behandlingen

Läkartidningen, Läkartidningen Förlag 2017, Vol. 114, (7)

von Wachenfeldt, Anna; Andersson, Anne; Fornander, Tommy; et al.

Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: a nested case-control study

PLOS ONE, PLOS one 2015, Vol. 10, (10)

Clendenen, Tess V.; Ge, Wenzhen; Koenig, Karen L.; et al.

Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study

International Journal of Cancer, Vol. 136, (11) : 2640-2648

McKenzie, Fiona; Ferrari, Pietro; Freisling, Heinz; et al.

Risk of second primary malignancies in women with breast cancer: Results from the European prospective investigation into cancer and nutrition (EPIC)

International Journal of Cancer, Vol. 137, (4) : 940-948

Ricceri, Fulvio; Fasanelli, Francesca; Giraudo, Maria Teresa; et al.

Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study

Breast Cancer Research, Vol. 17

Tikk, Kaja; Sookthai, Disorn; Fortner, Renee T.; et al.

Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases

Cancer Epidemiology, Biomarkers and Prevention, Vol. 23, (6) : 934-945

Ali, Alaa M. G.; Schmidt, Marjanka K.; Bolla, Manjeet K.; et al.

Weight change in middle adulthood and breast cancer risk in the EPIC-PANACEA study

International Journal of Cancer, Vol. 135, (12) : 2887-2899

Emaus, Marleen J.; van Gils, Carla H.; Bakker, Marije F.; et al.

Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status: A prospective study within the EPIC cohort

International Journal of Cancer, Vol. 134, (11) : 2683-2690

Kaaks, Rudolf; Johnson, Theron; Tikk, Kaja; et al.

Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status-Results from the EPIC cohort

International Journal of Cancer, Vol. 134, (8) : 1947-1957

Kaaks, Rudolf; Tikk, Kaja; Sookthai, Disorn; et al.

Dietary fat intake and development of specific breast cancer subtypes

Journal of the National Cancer Institute, Oxford University Press 2014, Vol. 106, (5) : dju068-

Sieri, Sabina; Chiodini, Paolo; Agnoli, Claudia; et al.

Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort

Annals of Oncology, Oxford University Press 2014, Vol. 25, (7) : 1422-1428

Tikk, Kaja; Sookthai, Disorn; Johnson, Theron; et al.

Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: A nested case-control study

International Journal of Cancer, Vol. 133, (7) : 1689-1700

Kühn, Tilman; Kaaks, Rudolf; Becker, Susen; et al.

Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: A cohort study

International Journal of Cancer, Wiley-Blackwell 2013, Vol. 132, (11) : 2619-2629

Ritte, Rebecca; Lukanova, Annekatrin; Tjonneland, Anne; et al.

Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study

BMC Cancer, BioMed Central 2013, Vol. 13 : Article Number: 584-

Ritte, Rebecca; Tikk, Kaja; Lukanova, Annekatrin; et al.

Physical activity and risk of breast cancer overall and by hormone receptor status: The European prospective investigation into cancer and nutrition

International Journal of Cancer, Vol. 132, (7) : 1667-1678

Steindorf, Karen; Ritte, Rebecca; Eomois, Piia-Piret; et al.

Long-term side effects after treatment of Hodgkin's lymphoma

Umeå University medical dissertations, 1416

Andersson, Anne

Long term risk of infections in Hodgkin lymphoma long-term survivors

British Journal of Haematology, Vol. 154, (5) : 661-663

Andersson, Anne; Enblad, Gunilla; Gustavsson, Anita; et al.

Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors: retrospective cohort analyses and a concept for prospective intervention

International Journal of Cancer, Vol. 124, (8) : 1914-1917

Andersson, Anne; Näslund, Ulf; Tavelin, Björn; et al.

Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma

British Journal of Cancer, Vol. 98, (5) : 1001-1005

Andersson, Anne; Enblad, Gunilla; Tavelin, Björn; et al.

Cardiovascular side effects following treatment of Hodgkin’s lymphoma: comorbidity factors and a strategy for intervention

Andersson, Anne; Enblad, Gunilla; Gustavsson, Anita; et al.

Visa publikationer i DiVA

Forskargrupper

Gruppmedlem

Håkan Jonsson lab

Forskningsprojekt

1 december 2023 till 31 december 2028

Biomarkörer för tidig upptäckt av bröstcancer